Moderna says the Food and Drug Administration has agreed to review its new mRNA-based flu shot after a highly public dispute about the vaccine’s trial design and initial refusal to file.
Posts tagged as “FDA review”
The FDA declined to review an application for a new mRNA flu vaccine. The decision highlights ongoing regulatory scrutiny around novel vaccine platforms.